Immunogen, Inc. (IMGN) Reports Q4 EPS Loss of $0.23
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Tweet
Share
E-mailGet Alerts IMGN Hot Sheet
Price: $31.25 --0%
Financial Fact:
License and milestone fees: 76K
Today's EPS Names:
FCNCA, FCNCA, RCBC, More
Financial Fact:
License and milestone fees: 76K
Today's EPS Names:
FCNCA, FCNCA, RCBC, More
Join SI Premium – FREE
Immunogen, Inc. (NASDAQ: IMGN) reported Q4 EPS of ($0.23), $0.01 better than the analyst estimate of ($0.24). Revenue for the quarter came in at $6.5 million versus the consensus estimate of $4.41 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Boston Beer Co. (SAM) Tops Q3 EPS by 15c; offers guidance
- Infosys Limited (INFY) Reports In-Line Q3 EPS
- World Acceptance (WRLD) Tops Q2 EPS by 113c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
